You are here: Industry Insights > Acquisition

News List

Melinta to Acquire Tetraphase Pharmaceuticals americanpharmaceuticalreview
June 19, 2020
Melinta Therapeutics announced that on June 4, 2020, it entered into a definitive merger agreement with Tetraphase Pharmaceuticals.
Supernus Completes Acquisition of CNS Portfolio from US WorldMeds americanpharmaceuticalreview
June 19, 2020
Supernus Pharmaceuticals announced the closing of the acquisition of the CNS portfolio of US WorldMeds, a privately-held biopharmaceutical company.
The Creative Engagement Group buys Cormis pharmatimes
June 17, 2020
The Creative Engagement Group (TCEG), part of the Huntsworth healthcare and communications group, has bought Cormis, a strategic communications and training consultancy for the pharmaceutical industry.
Novo Nordisk to acquire Corvidia Therapeutics for $725m pharmaceutical-technology
June 15, 2020
Danish healthcare company Novo Nordisk has signed a definitive agreement to acquire US-based Corvidia Therapeutics, which develops and commercialises therapies for cardio-renal diseases, for an upfront payment of $725m.
Dr Reddy’s Laboratories completes acquisition of Wockhardt’s select business divisions expresspharma
June 11, 2020
The acquired divisions comprise a portfolio of 62 brands in multiple therapy areas such as respiratory, neurology, VMS, dermatology, gastroenterology, pain and vaccines.
Cipla acquires stake in GoApptiv expresspharma
June 10, 2020
The acquisition of 21.85 per cent stake on a fully diluted basis will be completed in two stages.
Ajinomoto Bio-Pharma Completes Acquisition of Granules OmniChem Joint Venture in India americanpharmaceuticalreview
June 03, 2020
Ajinomoto Bio-Pharma Services has completed the acquisition of Granules OmniChem Private Limited, purchasing the remaining 50 percent ownership interest from its joint venture partner, Granules India Limited.
Boehringer Ingelheim acquires Northern Biologics’ preclinical cancer antibody pipeline expresspharma
May 18, 2020
The acquisition provides assets targeting tumour stroma and myeloid cells.
AbbVie completes acquisition of Allergan expresspharma
May 14, 2020
The transaction significantly expands and diversifies AbbVie’s revenue base and complements existing leadership positions in immunology.
FTC accepts proposal for to AbbVie acquire Allergan for $63 billion europeanpharmaceuticalreview
May 12, 2020
AbbVie and Allergan have announced the Federal Trade Commission has accepted AbbVie’s pending acquisition of Allergan for $63 billion.